The participant registry will assist with study recruitment for current and future studies at the UNC-CH Adams School of Dentistry.

Have you been diagnosed with a plasma cell disorder? You may be able to join a registry to help us learn more about the effects of plasma cell disorders on different aspects of life.

Have you been diagnosed with melanoma? If so, you may be eligible to take part in a research study looking at the safety of giving a combination of drugs called Ulixertinib and Palbociclib to patients with advanced melanoma.

The purpose of this study is to learn more about three kidney diseases called nephrotic syndrome: Focal Segmental Glomerulosclerosis (FSGS), Minimal Change Disease (MCD), and Membranous Nephropathy (MN). By collecting health information and laboratory samples from individuals who have these diseases and by making this information available to researchers, we hope to gain new knowledge about these diseases and to find better treatments for them.

We are looking for patients with kidney disease and healthy controls (no kidney disease) to provide blood samples, fill out surveys, and provide health related information to help investigators learn more about how to better diagnose and treat kidney disease. The information you provide will go into a "library" of data for doctors and researchers across the world to use for research projects. If you are a kidney patient, we are able to use your information to find out if you are eligible for treatment studies/other studies in the future.

Do you have bladder, kidney, prostate, or another genitourinary cancer diagnosis? If so, you may be able to take part in a research study collecting specimens (e.g., blood, urine, saliva, tissue) during your already scheduled appointments. Collecting these specimens may help researchers develop new ways to detect cancer earlier or to more effectively treat cancer.

Despite the ground-breaking benefits and scientific advancements in Chimeric Antigen Receptor T-cell (CAR-T) cell therapy, there are significant challenges for CAR-T clinical trials in diseases outside of cancer. These barriers include lack of awareness and knowledge, apprehension and hesitation amongst patients and healthcare providers, logistical and financial concerns, and inequitable access to this new therapy. This project aims to address these challenges by developing innovative strategies to enhance access to participation in CAR-T clinical trials in lupus and autoimmune diseases. The insights and strategies developed from this work will be used to inform and advance the reach, relevance, and implementation of innovative strategies to advance opportunity and accessibility for cell-based therapy trials in other disease states, beyond the example of lupus and autoimmune diseases.

We are trying to develop the prototype pf a mobile health app for smoking cessation and want to get the input of members of the community who use tobacco products.

The purpose of this research study is to monitor how well patients with fatty liver disease can follow clinician-recommended diet and exercise before their liver surgery. Our goal is to understand patient adherence to weight-related goals, weight loss, physical activity, and improved liver health. You are being asked to be in the study because you are a patient with fatty liver disease planning to have liver surgery.

We aim to understand how people judge different stories and statements to be truthful or present information in different ways.